2022-23 U.S. Seasonal Influenza Vaccine Overview
Key Points: COVID In today’s Recommendation for Industry, we discuss 2022-23 U.S. Seasonal Influenza Vaccine Overview. Read more below. Paxlovid, molnupiravir benefit older COVID-19 patients,
Day: August 30, 2022
Why BE Labeling Carries Risks for Manufacturers
Intended to help consumers easily identify any bioengineered (BE) ingredients in foods, the USDA BE foods labeling standard, which became mandatory this year, is carrying
